Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
International Journal of Oral Science|April 17, 2025
Lysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppressionAmit Kumar Chakraborty, Rajnikant Dilip Raut, Kisa Iqbal, et al.The EMBO Journal|February 11, 2015
SIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitisYaíma L Lightfoot, Kurt Selle, Tao Yang, et al.Veterinary Immunology and Immunopathology|January 2, 2021
Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrateMatthew J Cascio, Elizabeth M Whitley, Bikash Sahay, et al.Hypertension (Dallas, Tex. : 1979)|April 15, 2015
Gut dysbiosis is linked to hypertensionTao Yang, Monica M Santisteban, Vermali Rodriguez, et al.Viruses|February 6, 2019
Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency VirusesBikash Sahay, Alek M Aranyos, Meerambika Mishra, et al.Human Vaccines & Immunotherapeutics|August 14, 2020
Protection against <i>Borreliella burgdorferi</i> infection mediated by a synthetically engineered DNA vaccineGhiabe H Guibinga, Bikash Sahay, Heather Brown, et al.Viruses|April 28, 2023
Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine DevelopmentJanet K Yamamoto, Lekshmi K Edison, Dawne K Rowe-Haas, et al.Nano Letters|September 28, 2018
Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer ImmunotherapyElias J Sayour, Adam Grippin, Gabriel De Leon, et al.Journal for Immunotherapy of Cancer|November 11, 2025
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumorsSheila Carrera-Justiz, Mahya Aghaee, Sadeem Qdaisat, et al.Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
mRNA aggregates harness danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.Pageof 6